跳至主要内容
临床试验/DRKS00022789
DRKS00022789已完成不适用

Investigation of Curcumin on symptoms of knee osteoarthritis: a two months, double blind, Placebo-controlled, randomized pilot study

Wacker Chemie AG0 个研究点目标入组 48 人开始时间: 2020年8月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 75 Years(—)
性别
All

入选标准

  • Women and men with painful knee joints e.g. defined as e.g. WOMAC pain score part A + stiffness score part B at least 15 points;
  • Volunteers with primary osteoarthritis who are not expected to require surgical treatment for at least three months after inclusion;
  • Known X-ray finding (Kellgren score of 1 to 3; X-ray not older than 24 months);
  • Discomfort over a period of at least 3 months

排除标准

  • BMI = 32 kg/m2, Medical treatment of joint disease besides Paracetamol as analgesic medication for emergency treatment; Inflammatory, infectious or metabolic joint disorder; Artificial joint replacement in knees or hip; Surgery within the last 6 months in knees or hip; Intra-articular therapy within the last 3 months; Oral cartilage treatment within the last 3 months

研究者

相似试验